Dr. Patrick Kaszubski
Ophthalmology (Ophthalmology Physician)
- Medicare participating
At a glance
- Medical school
- New York University School of Medicine (2016)
- Years since graduation
- 10
- In the NPI registry since
- 2016
- Medicare patients seen, 2024
- 533
The NPI date is when this clinician registered for a National Provider Identifier, the billing number used on health claims. It is not a license, graduation or board-certification date. What an NPI is
Education and training
- 2016Medical school: New York University School of Medicine
- 2016Registered with an NPI (national billing number; not a license date)
Undergraduate school, residency, fellowship, licensing exams and board certification aren’t in public federal data. Board certification can be confirmed with the certifying board (ABMS member boards for MDs, AOA boards for DOs).
Specialties and state licenses
-
Ophthalmology Physician primary
VA license 0101271730 -
Glaucoma Specialist (Ophthalmology) Physician
VA license 0101271730
As reported to the NPI registry. To confirm a license is current, check the state medical board.
Where they work
Medical groups
- Northern Virginia Ophthalmology Assoc PC (19 clinicians)
Hospitals this clinician lists with Medicare, and groups they bill Medicare through (Care Compare). Affiliation doesn’t mean they see patients at every location.
Medicare patients and services
- Medicare patients, 2024
- 533
- Services billed
- 1,832
- Patients’ average age
- 75
| Service | Times | Patients |
|---|---|---|
| Established patient problem focused exam of visual system | 371 | 245 |
| Established patient complete exam of visual system | 206 | 201 |
| Exam of visual field with extended testing | 171 | 136 |
| Imaging of optic nerve | 157 | 150 |
| New patient complete exam of visual system | 97 | 97 |
| Exam of the internal drainage system of eye | 80 | 80 |
| Established patient office or other outpatient visit, 30-39 minutes | 68 | 66 |
| Ultrasound scan of cornea to determine thickness | 60 | 60 |
| Imaging of retina | 50 | 46 |
| Measurement of corneal curvature and depth of eye | 41 | 29 |
Medicare fee-for-service only. CMS leaves out services billed for fewer than 11 patients. These figures describe a practice’s Medicare work; they aren’t a measure of quality.
Medicare prescriptions
| Drug | Prescriptions |
|---|---|
| Latanoprost Other prescribers in Falls Church, VA | 424 |
| Brimonidine Tartrate Other prescribers in Falls Church, VA | 145 |
| Dorzolamide-Timolol (dorzolamide hcl/timolol maleat) Other prescribers in Falls Church, VA | 126 |
| Timolol Maleate Other prescribers in Falls Church, VA | 88 |
| Prednisolone Acetate Other prescribers in Falls Church, VA | 52 |
| Rhopressa (netarsudil mesylate) | 40 |
| Dorzolamide Hcl Other prescribers in Falls Church, VA | 34 |
| Lumigan (bimatoprost) Other prescribers in Falls Church, VA | 33 |
| Acetazolamide Other prescribers in Falls Church, VA | 26 |
| Brinzolamide | 21 |
Prescriptions filled under Medicare Part D, including refills. CMS leaves out drugs prescribed fewer than 11 times.
Payments from drug and device companies
In 2025, 4 companies reported 5 payments worth $377 in total to this clinician.
| Sight Sciences, Inc. | $226 |
|---|---|
| Bausch & Lomb Americas Inc. | $106 |
| Alcon Vision LLC | $27.14 |
| AbbVie Inc. | $18.06 |
| Food and Beverage | $377 |
|---|
From CMS Open Payments. A payment is not evidence of wrongdoing; many are for consulting, teaching or meals. Clinicians can review and dispute their records with CMS.
Industry-funded research
Named as a principal investigator on 2 industry-funded studies in 2025, from 1 companies. The companies reported $5,635 in research payments for these studies, mostly to the institutions running them.
- Study to Assess Change in Disease Activity and Adverse Events of Ab Externo Approach for Glaucoma Gel Stent (XEN45) Implantation In Participants Aged 45 Years or Older With Open-Angle Glaucoma
AbbVie Inc. - Study to Assess Change in Disease Activity and Adverse Events of Ab Externo Approach for Glaucoma Gel Stent (XEN45) Implantation In Participants Aged 45 Years or Older With Open-Angle Glaucoma
AbbVie Inc. · Completed · NCT05411198
From CMS Open Payments research payments, where companies name up to five principal investigators per payment. Research payments usually go to hospitals, universities and research sites, not to the investigator personally. A payment is not evidence of wrongdoing.